Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

NCT02731287 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hemangioma

Interventions

DRUG: Timolol
DRUG: Placebo

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau